World's Best Scientists 2026 revealed!
Manuel Romero-Gómez

Manuel Romero-Gómez

D-Index & Metrics

Medicine

D-Index
90
Citations
38238
World Ranking
12041
National Ranking
167

Overview

Manuel Romero-Gómez is affiliated with the University of Seville in Spain and has an extensive publication record primarily in the field of Medicine. Their research focuses largely on hepatology, with notable contributions in epidemiology, endocrinology, diabetes and metabolism, surgery, and molecular biology. The subfields reflect a multidisciplinary approach aligned with liver diseases and associated metabolic conditions.

The scientist's recent papers include significant work on fatty liver disease, specifically around the evolving nomenclature and diagnostic criteria. Key publications are:

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement, 2020, Journal of Hepatology
  • MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease, 2020, Gastroenterology
  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature, 2023, Hepatology
  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature, 2023, Journal of Hepatology
  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature, 2023, Annals of Hepatology

The publication venues where Manuel Romero-Gómez frequently contributes include:

  • Journal of Hepatology
  • Clinical Gastroenterology and Hepatology
  • Liver International
  • Hepatology
  • JHEP Reports

Frequent co-authors collaborating with this researcher are:

  • Javier Ampuero
  • Elisabetta Bugianesi
  • Vincent Wai-Sun Wong
  • Rocío Gallego-Durán
  • José Luís Calleja

The main topics of work revolve around:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • Liver Diseases and Immunity
  • Hepatitis C virus research
  • Alcohol Consumption and Health Effects
  • Diet and metabolism studies

Manuel Romero-Gómez's research contributions number 893 publications in Medicine, with focused expertise demonstrated by 331 publications in Epidemiology and 229 in Hepatology. The work spans clinical and molecular aspects linked to liver health, metabolic disorders, and immunological factors related to hepatic diseases.

Best Publications

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

    Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee

  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier

  • Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.

    Eduardo Vilar-Gomez;Yadina Martinez-Perez;Luis Calzadilla-Bertot;Ana Torres-Gonzalez

  • Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

    Chris Estes;Quentin M. Anstee;Maria Teresa Arias-Loste;Heike Bantel

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

    David Ellinghaus;Frauke Degenhardt;Luis Bujanda;Maria Buti

  • Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

    Raúl J. Andrade;M. Isabel Lucena;M. Carmen Fernández;Gloria Pelaez

  • Treatment of NAFLD with diet, physical activity and exercise

    Manuel Romero-Gómez;Shira Zelber-Sagi;Michael Trenell

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

    Manuel Romero-Gómez;Maria Del Mar Viloria;Raúl J. Andrade;Javier Salmerón

  • Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

    Zobair Younossi;Maria Stepanova;Janus P. Ong;Ira M. Jacobson

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

    Stuart McPherson;Stuart McPherson;Tim Hardy;Tim Hardy;Jean-Francois Dufour;Salvatore Petta

  • Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

    Eduardo Vilar-Gomez;Eduardo Vilar-Gomez;Luis Calzadilla-Bertot;Vincent Wai-Sun Wong;Marlen Castellanos

  • A dynamically young and perturbed Milky Way disk

    T. Antoja;A. Helmi;M. Romero-Gómez;D. Katz

  • Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

    Manuel Romero-Gómez;Fernando Boza;Maria Sierra García-Valdecasas;Emilio García

  • Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury is Influenced by Multiple HLA Class I and II Alleles

    M. Isabel Lucena;Mariam Molokhia;Yufeng Shen;Thomas J. Urban

  • A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.

    Sven M Francque;Pierre Bedossa;Vlad Ratziu;Quentin M Anstee

  • Phenotypic characterization of idiosyncratic drug‐induced liver injury: The influence of age and sex

    M. Isabel Lucena;Raúl J. Andrade;Neil Kaplowitz;Miren García‐Cortes

  • Value of the critical flicker frequency in patients with minimal hepatic encephalopathy

    Manuel Romero-Gómez;Juan Córdoba;Rodrigo Jover;Juan A. del Olmo

  • Outcome of acute idiosyncratic drug‐induced liver injury: Long‐term follow‐up in a hepatotoxicity registry

    Raúl J. Andrade;M. Isabel Lucena;Neil Kaplowitz;Beatriz García‐Muņoz

Frequent Co-Authors

Elisabetta Bugianesi
Elisabetta Bugianesi University of Turin
Quentin M. Anstee
Quentin M. Anstee Newcastle University
Javier García-Samaniego
Javier García-Samaniego Hospital Universitario La Paz
Jacob George
Jacob George University of Sydney
Vincent Wai-Sun Wong
Vincent Wai-Sun Wong Chinese University of Hong Kong
Ramon Planas
Ramon Planas University of Barcelona
Zobair M. Younossi
Zobair M. Younossi Inova Health System
Agustín Albillos
Agustín Albillos University of Alcalá
Maria Buti
Maria Buti Instituto de Salud Carlos III
Xavier Forns
Xavier Forns University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine or healthcare, several online degrees and certifications present accessible entry points and advancement opportunities. For those interested in the technical and administrative side, medical billing and coding schools online offer flexible programs that can lead to stable healthcare roles, often with the added benefit of financial aid.

Many students pursue nursing pathways for direct patient care. An lpn program without teas test is ideal for those seeking a streamlined entry into practical nursing, removing common exam barriers.

For advancement or leadership, a degree in healthcare administration can prepare you for roles in managing hospitals, clinics, or healthcare systems, with accelerated online options speeding up your timeline.

Registered nurses looking to expand their skills can enroll in rn to np programs, bridging the gap to become nurse practitioners in specialized fields. These pathways offer flexibility for working professionals and open new avenues in the evolving healthcare sector.

Best Scientists Citing Manuel Romero-Gómez

Trending Scientists